The U.S. Food & Drug Administration (FDA) has questionably authorised emergency use of both the Pfizer and Moderna mRNA Covid-19 injections for use among children aged 6 months and above despite data from the UK’s Office for National Statistics revealing that children are 82 to 303x more likely to die following Covid-19 vaccination than children who have not had the Covid-19 vaccine.
On June 17th 2022, the U.S. Food and Drug Administration (FDA) criminally extended the emergency use authorisation of the mRNA Covid-19 injections for use in children as young as 6 months.
There has never been an emergency in regard to Covid-19 infection among children. Two years of evidence show the alleged disease has only adversely affected the elderly and vulnerable. Children have been unlucky to suffer symptoms more severe than those associated with the common cold.
But despite this fact, the FDA has decided it is perfectly safe to administer an experimental injection to babies and toddlers, with FDA Commissioner Robert Califf saying –
“Many parents, caregivers and clinicians have been waiting for a vaccine for younger children and this action will help protect those down to 6 months of age. As we have seen with older age groups, we expect that the vaccines for younger children will provide protection from the most severe outcomes of COVID-19, such as hospitalization and death.